In an effort to reduce the supply of opioids, the Drug Enforcement Administration and the Department of Justice proposed a quota reduction this month for U.S. manufacturing of certain drugs in 2019. The proposal announced Aug. 16 would decrease “manufacturing quotas for the six most frequently misused opioids for 2019 by an average 10 percent as compared to the 2018 amount,” according to the DEA announcement. “Once the aggregate quota is set, DEA allocates individual manufacturing and procurement quotas to those manufacturers that apply for them. DEA may revise a company’s quota at any time during the year if change is warranted due to increased or decreased sales or exports, new manufacturers entering the market, new product development or product recalls,” according to the DEA’s announcement.
BREAKING: Local legislation could provide specific property tax relief to Dawson County seniors. Here’s the latest.